Erika Carmel-Tech Ltd (ERKA) - Net Assets
Based on the latest financial reports, Erika Carmel-Tech Ltd (ERKA) has net assets worth ILA13.40 Million ILA as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA31.51 Million) and total liabilities (ILA18.11 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA13.40 Million |
| % of Total Assets | 42.52% |
| Annual Growth Rate | 37.06% |
| 5-Year Change | 67.64% |
| 10-Year Change | N/A |
| Growth Volatility | 358.64 |
Erika Carmel-Tech Ltd - Net Assets Trend (2019–2024)
This chart illustrates how Erika Carmel-Tech Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Erika Carmel-Tech Ltd (2019–2024)
The table below shows the annual net assets of Erika Carmel-Tech Ltd from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA15.04 Million | -36.62% |
| 2023-12-31 | ILA23.73 Million | -44.39% |
| 2022-12-31 | ILA42.67 Million | -51.55% |
| 2021-12-31 | ILA88.06 Million | +881.74% |
| 2020-12-31 | ILA8.97 Million | +188.70% |
| 2019-12-31 | ILA3.11 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Erika Carmel-Tech Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7881800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA1.04 Million | 6.93% |
| Other Comprehensive Income | ILA4.78 Million | 31.82% |
| Other Components | ILA88.10 Million | 585.86% |
| Total Equity | ILA15.04 Million | 100.00% |
Erika Carmel-Tech Ltd Competitors by Market Cap
The table below lists competitors of Erika Carmel-Tech Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Alternative Liquidity Fund Limited
LSE:ALF
|
$5.33 Million |
|
DXN Ltd
AU:DXN
|
$5.34 Million |
|
Can Fite Biopharma Ltd
TA:CANF
|
$5.34 Million |
|
Brera Holdings PLC Class B Ordinary Shares
NASDAQ:BREA
|
$5.34 Million |
|
Zephyr Minerals Ltd
V:ZFR
|
$5.33 Million |
|
Volt Carbon Technologies Inc
V:VCT
|
$5.33 Million |
|
Golden Dragon Mining Ltd
AU:GDR
|
$5.33 Million |
|
ABAS Protect AB
ST:ABAS
|
$5.32 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Erika Carmel-Tech Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 23,727,000 to 15,037,000, a change of -8,690,000 (-36.6%).
- Net loss of 9,470,000 reduced equity.
- Other comprehensive income increased equity by 729,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-9.47 Million | -62.98% |
| Other Comprehensive Income | ILA729.00K | +4.85% |
| Other Changes | ILA51.00K | +0.34% |
| Total Change | ILA- | -36.62% |
Book Value vs Market Value Analysis
This analysis compares Erika Carmel-Tech Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 132.31x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 636.51x to 132.31x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | ILA0.03 | ILA19.10 | x |
| 2020-12-31 | ILA0.09 | ILA19.10 | x |
| 2021-12-31 | ILA0.86 | ILA19.10 | x |
| 2022-12-31 | ILA0.41 | ILA19.10 | x |
| 2023-12-31 | ILA0.23 | ILA19.10 | x |
| 2024-12-31 | ILA0.14 | ILA19.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Erika Carmel-Tech Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -62.98%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -24.95%
- • Asset Turnover: 1.09x
- • Equity Multiplier: 2.31x
- Recent ROE (-62.98%) is below the historical average (-5.12%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 75.41% | 4.61% | 1.95x | 8.39x | ILA2.03 Million |
| 2020 | 138.94% | 14.53% | 1.80x | 5.32x | ILA11.57 Million |
| 2021 | -24.76% | -22.52% | 0.77x | 1.42x | ILA-30.61 Million |
| 2022 | -76.32% | -64.71% | 0.74x | 1.60x | ILA-36.83 Million |
| 2023 | -81.01% | -64.32% | 0.64x | 1.98x | ILA-21.59 Million |
| 2024 | -62.98% | -24.95% | 1.09x | 2.31x | ILA-10.97 Million |
Industry Comparison
This section compares Erika Carmel-Tech Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $56,492,125
- Average return on equity (ROE) among peers: -144.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Erika Carmel-Tech Ltd (ERKA) | ILA13.40 Million | 75.41% | 1.35x | $5.33 Million |
| Allmed Solutions Ltd (ALMD) | $32.16 Million | -76.63% | 0.39x | $9.22 Million |
| Bio-View Ltd (BIOV) | $24.95 Million | 10.12% | 0.48x | $5.55 Million |
| Erech Finance Cahalacha Ltd (EFNC) | $28.37 Million | -88.27% | 1.44x | $1.59 Million |
| Epitomee Medical Ltd (EPIT) | $39.45 Million | -39.02% | 0.40x | $70.99 Million |
| Human Xtensions Ltd (HUMX) | $61.78 Million | -72.18% | 0.17x | $2.12 Million |
| Ilex Medical (ILX) | $259.96 Million | 0.00% | 1.31x | $162.27 Million |
| Pulsenmore Ltd (PULS) | $3.75 Million | -126.31% | 0.60x | $22.89 Million |
| Sofwave Medical Ltd (SOFW) | $1.53 Million | -762.36% | 2.14x | $403.02 Million |
About Erika Carmel-Tech Ltd
Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. T… Read more